You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 5, May 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Ataxia
 •Neurogenetics
 •Neurology, Other
 •Genetic Disorders
 •Genetics, Other
 •Alert me on articles by topic

Hereditary Spastic Paraplegia and Hereditary Ataxia

Part 2: A Family Demonstrating Various Phenotypic Manifestations With the SCA3 Genotype

William M. Landau, MD; Robert E. Schmidt, MD, PhD; Ronald C. McGlennen, MD; Stephen G. Reich, MD

Arch Neurol. 2000;57:733-739.

Background  Clinical descriptions of the dominantly inherited ataxic motor syndromes in a 7-generation family of German origin were first reported in 1951.

Objective  To provide follow-up clinical, pathological, and genetic data for 9 patients in this family.

Design  Clinical histories and neurologic findings, gross and microscopic pathological features, and DNA analysis.

Results  Clinical presentations in this closely followed up portion of the family include fairly uniform ataxic and upper motor neuron symptoms. Nystagmus was a conspicuous and early sign, but generational anticipation was not evident. Although often present, amyotrophy was not a major source of disability. Major pathological degeneration was noted in the pons, spinal cord, and upper brainstem, where ubiquitin-immunoreactive intranuclear inclusion bodies were demonstrated. The diagnosis of Machado-Joseph disease (SCA3 [spinocerebellar ataxia type 3] genotype) was established from autopsy tissue in 1 patient and from blood specimens in 6 others.

Conclusions  Clinical variation within this family and between this family and families with the SCA1 and SCA3 genotypes is so broad as to make the genetic diagnosis from clinical criteria alone practically impossible. The pathological definition of Machado-Joseph disease is more reliable, but some findings do overlap those of other genotypes. To our knowledge, the basis for the phenotypic variations in Machado-Joseph disease, genetic or otherwise, has not been established.


From the Departments of Neurology (Dr Landau) and Pathology (Dr Schmidt), Washington University School of Medicine, St Louis, Mo; the Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis (Dr McGlennen); and the Department of Neurology, The Johns Hopkins School of Medicine, Baltimore, Md (Dr Reich).


RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2000;57(5):762-763.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Spastic paraplegia, ataxia, mental retardation (SPAR): A novel genetic disorder
Hedera et al.
Neurology 2002;58:411-416.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.